Departement de Genetique, DMU Biologie-Pathologie, GH Mondor-Chenevier, AP-HP, F-94010 Creteil, France.
INSERM, IMRB, Paris Est Creteil University, F-94010 Creteil, France.
Genes (Basel). 2021 Apr 29;12(5):670. doi: 10.3390/genes12050670.
In families without a Cystic Fibrosis (CF) history, fetal ultrasound bowel abnormalities can unexpectedly reveal the disease. Isolated or in association, the signs can be fetal bowel hyperechogenicity, intestinal loop dilatation and non-visualization of fetal gallbladder. In these cases, search for CF transmembrane conductance regulator () gene mutations is part of the recommended diagnostic practices, with a search for frequent mutations according to ethnicity, and, in case of the triad of signs, with an exhaustive study of the gene. However, the molecular diagnosis remains a challenge in populations without well-known frequent pathogenic variants. We present a multiethnic cohort of 108 pregnancies with fetal bowel abnormalities in which the parents benefited from an exhaustive study of the gene. We describe the new homozygous p.Cys1410* mutation in a fetus of African origin. We did not observe the most frequent p.Phe508del mutation in our cohort but evidenced variants undetected by our frequent mutations kit. Thanks to the progress of sequencing techniques and despite the difficulties of interpretation occasionally encountered, we discuss the need to carry out a comprehensive study in all patients in case of fetal bowel abnormalities.
在没有囊性纤维化 (CF) 病史的家庭中,胎儿超声肠异常可能会意外揭示该疾病。孤立或相关的迹象可以是胎儿肠回声增强、肠袢扩张和胎儿胆囊不可见。在这些情况下,根据种族搜索 CF 跨膜电导调节剂 () 基因突变是推荐的诊断实践的一部分,并且在存在三联征的情况下,对该基因进行详尽研究。然而,在没有已知常见致病性变异的人群中,分子诊断仍然具有挑战性。我们介绍了一个多民族队列,其中 108 例胎儿肠异常的父母受益于对 基因的详尽研究。我们描述了一个起源于非洲的胎儿中纯合子 p.Cys1410*突变。我们在队列中没有观察到最常见的 p.Phe508del 突变,但确实检测到了我们的常见突变试剂盒未检测到的变异。由于测序技术的进步,尽管偶尔会遇到解释上的困难,我们讨论了在存在胎儿肠异常的情况下,对所有患者进行全面 研究的必要性。